Kapil N Bhalla Selected Research

Kapil N Bhalla Research Topics

Disease

35	Neoplasms (Cancer) 11/2023 - 01/2002
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 08/2002
10	Breast Neoplasms (Breast Cancer) 09/2017 - 01/2002
6	Leukemia 09/2017 - 05/2009
5	Primary Myelofibrosis (Myelosclerosis) 01/2017 - 10/2012
4	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 12/2009
4	Lymphoma (Lymphomas) 01/2021 - 01/2005
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 07/2009
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 04/2002
3	Triple Negative Breast Neoplasms 07/2014 - 04/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2023 - 01/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 05/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2012 - 10/2004
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2009 - 04/2009
1	Microsatellite Instability 06/2023
1	Disease Progression 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019
1	Infections 01/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 07/2017
1	Rheumatoid Arthritis 05/2014
1	Pulmonary Edema 12/2013
1	Essential Thrombocythemia 10/2013
1	Polycythemia Vera 10/2013
1	Lung Neoplasms (Lung Cancer) 07/2013
1	Adenocarcinoma 11/2012

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 06/2023 - 07/2003
11	Histone Deacetylase InhibitorsIBA 07/2014 - 09/2005
10	PanobinostatIBA 01/2020 - 04/2009
4	ChromatinIBA 01/2021 - 06/2005
4	Vorinostat FDA Link 09/2017 - 04/2009
4	Histones (Histone)IBA 09/2017 - 09/2009
4	Phosphotransferases (Kinase)IBA 01/2017 - 12/2011
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2011 - 07/2009
3	Transcription Factors (Transcription Factor)IBA 05/2024 - 07/2006
3	venetoclaxIBA 11/2022 - 01/2018
3	CateninsIBA 01/2021 - 01/2019
3	Bortezomib (Velcade)FDA Link 01/2020 - 01/2010
3	Histone Deacetylases (Histone Deacetylase)IBA 05/2014 - 01/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2009 - 04/2002
2	purineIBA 04/2024 - 12/2009
2	ibrutinibIBA 01/2020 - 09/2015
2	CCAAT-Enhancer-Binding ProteinsIBA 01/2020 - 10/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2012
2	Janus KinasesIBA 01/2017 - 10/2012
2	ruxolitinibIBA 01/2017 - 10/2012
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 12/2011
2	Arsenic Trioxide (Trisenox)FDA Link 01/2016 - 04/2002
2	Bcl-2-Like Protein 11IBA 01/2016 - 09/2015
2	Cisplatin (Platino)FDA LinkGeneric 07/2014 - 10/2004
2	Decitabine FDA Link 12/2013 - 05/2009
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 07/2013 - 07/2011
2	dactolisibIBA 05/2013 - 11/2012
2	bcr-abl Fusion ProteinsIBA 01/2011 - 05/2006
2	Endoplasmic Reticulum Chaperone BiPIBA 04/2010 - 01/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2003 - 01/2002
1	PLX51107IBA 11/2023
1	Azacitidine (5 Azacytidine)FDA Link 11/2023
1	Immune Checkpoint InhibitorsIBA 06/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022
1	Cladribine FDA LinkGeneric 11/2022
1	TransducinIBA 01/2021
1	snake venom protein C activatorIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	HomoharringtonineIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 09/2017
1	rebastinibIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	PeroxiredoxinsIBA 01/2016
1	AntioxidantsIBA 01/2016
1	Oxidants (Oxidizing Agents)IBA 01/2016
1	Peroxidase (Myeloperoxidase)IBA 01/2016
1	Sirtuin 2IBA 01/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2014
1	veliparibIBA 07/2014
1	Oncogene Proteins (Oncogene Protein)IBA 05/2014
1	Auranofin (Ridaura)FDA Link 05/2014
1	midostaurinIBA 12/2013
1	Janus Kinase 2IBA 10/2013
1	Janus Kinase InhibitorsIBA 05/2013
1	MTOR InhibitorsIBA 05/2013
1	Beclin-1IBA 04/2013
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2013
1	moesinIBA 04/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 11/2012
1	tozasertibIBA 09/2012
1	Aurora KinasesIBA 09/2012
1	Estrogens (Estrogen)FDA Link 04/2012
1	Chloroquine (Aralen)FDA LinkGeneric 04/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2012
1	TransferasesIBA 01/2012
1	Small Interfering RNA (siRNA)IBA 07/2011
1	nilotinib FDA Link 01/2011

Therapy/Procedure

17	Therapeutics 01/2022 - 06/2005
2	Induction Chemotherapy 01/2017 - 10/2004
1	Aftercare (After-Treatment) 09/2017
1	Artificial Respiration (Mechanical Ventilation) 12/2013
1	Investigational Therapies (Experimental Therapy) 10/2013